April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Effect of Panretinal Photocoagulation for Diabetic Retinopathy on Retinal Nerve Fiber Layer and Visual Field
Author Affiliations & Notes
  • Peng Lei
    University of Texas Southwestern, Dallas, TX
  • Jess T Whitson
    University of Texas Southwestern, Dallas, TX
  • Footnotes
    Commercial Relationships Peng Lei, None; Jess Whitson, Alcon (C), Allergan (C), Sucampo (C)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 5642. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Peng Lei, Jess T Whitson; Effect of Panretinal Photocoagulation for Diabetic Retinopathy on Retinal Nerve Fiber Layer and Visual Field. Invest. Ophthalmol. Vis. Sci. 2014;55(13):5642.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To evaluate whether panretinal photocoagulation (PRP) affects retinal nerve fiber layer (RNFL) thickness and visual field sensitivity.

Methods: Prospective study of approximately 6 months duration involving 34 eyes in the PRP treatment group and 30 eyes in the control group followed with spectral domain optical coherence tomography (SD-OCT) and Humphrey visual field (HVF) 24-2.

Results: Treatment group [SD-OCT RNFL average thickness difference +1.69 um +/- 6.56 SD (p=0.16), HVF mean deviation difference +0.52 +/- 2.30 SD (p=0.23)]. Control group [SD-OCT RNFL average thickness difference -0.59 um +/- 5.75 SD (p=0.60), HVF mean deviation difference -0.27 +/- 2.82 SD (p=0.68)]. Treatment subgroup without prior PRP [SD-OCT RNFL average thickness difference +4.83 um +/- 4.39 SD (p=0.003), HVF mean deviation difference +1.21 +/- 2.45 SD (p=0.13)]. Control subgroup without prior PRP [SD-OCT RNFL average thickness difference +1.23 um +/- 5.72 SD (p=0.45), HVF mean deviation difference +0.18 +/- 3.49 SD (p=0.87)]. Treatment subgroup <= 3 months follow-up (SD-OCT RNFL average thickness difference +2.52 um +/- 4.07 SD (p=0.01), HVF mean deviation difference +0.83 +/- 2.59 SD (p=0.17)]. Treatment subgroup > 3 months follow-up (SD-OCT RNFL average thickness difference +0.19 um +/- 7.77 SD (p=0.91), HVF mean deviation difference +0.10 +/- 2.21 SD (p=0.85)].

Conclusions: PRP treatment may initially cause RNFL thickening. SD-OCT RNFL thickening was statistically significant in the treatment subgroup without prior PRP and during the initial 3 months after PRP treatment. With time, the increase diminished and was not statistically significant in the > 3 months follow-up subgroup. The effects of PRP treatment on HVF mean deviation were not statistically significant. PRP treatment seemed to improve retinal sensitivity as HVF mean deviation improved initially but with time this improvement became negligible. The use of SD-OCT RNFL and HVF to diagnose and manage glaucoma with concomitant diabetic retinopathy requiring PRP should be done cautiously in order to avoid mistreatment.

Keywords: 629 optic nerve • 758 visual fields  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×